The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Histone Modifications and Cancer
Open accessAbstract
Histone posttranslational modifications represent a versatile set of epigenetic marks involved not only in dynamic cellular processes, such as transcription and DNA repair, but also in the stable maintenance of repressive chromatin. In this article, we review many of the key and newly identified histone modifications known to be deregulated in cancer and how this impacts function. The latter part of the article addresses the challenges and current status of the epigenetic drug development process as it applies to cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–229 of 229
Epigenetic alterations in hematopoietic malignancies
Chung, Y. R., Schatoff, E. M., & Abdel-Wahab, O. I. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1181-z · Cited by 60
Chang, P., Fitzgerald, L. D., Hsia, D. A., Izumiya, Y., Wu, C., Hsieh, W., Lin, S., Campbell, M., Lam, K. S., Luciw, P. A., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02485-10 · Cited by 56
The Expression of Histone Demethylase JMJD1A in Renal Cell Carcinoma
Guo, X., SHI, M., Sun, L.-G., WANG, Y., Gui, Y., Cai, Z., & DUAN, X. (2011) · Neoplasma · doi:10.4149/neo_2011_02_153 · Cited by 55
Prognostic Importance of Histone MethyltransferaseMLL5Expression in Acute Myeloid Leukemia
Damm, F., Oberacker, T., Thol, F. R., Surdziel, E., Wagner, K., Chaturvedi, A., Morgan, M. A., Bomm, K., Göhring, G., Lübbert, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1118 · Cited by 55
Hou, X., Li, Y., Luo, R., Fu, J., He, J., Zhang, L., & Yang, H.-X. (2012) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2012.02.180 · Cited by 54
Kang, M. Y., Lee, B. B., Kim, Y., Chang, D. K., Park, S. K., Chun, H.-K., Song, S. Y., Park, J., & Kim, D. (2007) · International Journal of Cancer · doi:10.1002/ijc.22953 · Cited by 53
Regulation of SIRT2 levels for human non-small cell lung cancer therapy
Li, Z., Xie, Q. R., Chen, Z., Lü, S., & Xia, W. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.05.013 · Cited by 52
Sen, N., Kumari, R., Singh, M. I., & Das, S. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.003 · Cited by 50
A Role for DOT1L in MLL -Rearranged Leukemias
Bernt, K. M., & Armstrong, S. A. (2011) · Epigenomics · doi:10.2217/epi.11.98 · Cited by 47
Roesch, A., Becker, B., Schneider‐Brachert, W., Hagen, I., Landthaler, M., & VOGT, T. M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700324 · Cited by 46
Epigenetics Gets Sweeter: O-GlcNAc Joins the “Histone Code”
Hanover, J. A. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.12.001 · Cited by 44
Mantle Cell Lymphoma: A Clinically Heterogeneous Disease in Need of Tailored Approaches
Shah, B. D., Martin, P., & Sotomayor, E. M. (2012) · Cancer Control · doi:10.1177/107327481201900307 · Cited by 44
Lohse, B., Nielsen, A. L., Kristensen, J. B. L., Helgstrand, C., Cloos, P. A., Olsen, L., Gajhede, M., Clausen, R. P., & Kristensen, J. L. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201101849 · Cited by 43
Plazas-Mayorca, M. D., Bloom, J. S., Zeißler, U., LeRoy, G., Young, N. L., DiMaggio, P. A., Krugylak, L., Schneider, R., & Garcia, B. A. (2010) · Molecular BioSystems · doi:10.1039/c003307c · Cited by 43
Inhibition of BET Recruitment to Chromatin As An Effective Treatment for MLL-Fusion Leukaemia
Dawson, M. A., Prinjha, R. K., Dittmann, A., Giotopoulos, G., Bantscheff, M., Chan, W.-I., Robson, S. C., Chung, C., Hopf, C., Savitski, M. M., et al. (2011) · Blood · doi:10.1182/blood.v118.21.55.55 · Cited by 43
Epigenetic Control of ImmunityPreprint
Busslinger, M., & Tarakhovsky, A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a024174 · Cited by 41
Chen, Y.-F., Luo, R.-Z., Li, Y., Cui, B.-K., Song, M., Yang, A.-K., & Chen, W.-K. (2012) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-012-2275-1 · Cited by 37
Müller, S., & Brown, P. J. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.154 · Cited by 32
Jennings, L. E., Measures, A. R., Wilson, B. G., & Conway, S. J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.197 · Cited by 29
Expression of HDAC9 in lung cancer--potential role in lung carcinogenesis.
Okudela, K., Mitsui, H., Suzuki, T., Woo, T., Tateishi, Y., Umeda, S., Saito, Y., Tajiri, M., Masuda, M., & Ohashi, K. (2014) · Europe PMC (PubMed Central) · Cited by 27
The Necessity of Chromatin: A View in PerspectivePreprint
Pirrotta, V. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019547 · Cited by 27
The Discovery of Histone DemethylasesPreprint
Shi, Y. G., & Tsukada, Y.-I. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022335 · Cited by 25
Lim, J.-H., Choi, Y.-J., Cho, C., & Park, J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.006 · Cited by 24
Pharmacological Inhibition of Bromodomain-Containing Proteins in InflammationPreprint
Schaefer, U. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018671 · Cited by 24
Tumor suppression by the histone demethylase UTX
Tsai, M.-C., Wang, J. K., & Chang, H. Y. (2010) · Cell Cycle · doi:10.4161/cc.9.11.11845 · Cited by 21
Imaoka, N., Hiratsuka, M., Osaki, M., Kamitani, H., Kambe, A., Fukuoka, J., Kurimoto, M., Nagai, S., Okada, F., Watanabe, T., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.1872 · Cited by 16
Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma
Lautz, T. B., Naiditch, J. A., Clark, S. H., Chu, F., & Madonna, M. B. (2012) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2012.03.039 · Cited by 14
Lohse, B., Nielsen, A. L., Kristensen, J. B. L., Helgstrand, C., Cloos, P. A., Olsen, L., Gajhede, M., Clausen, R. P., & Kristensen, J. L. (2011) · Angewandte Chemie · doi:10.1002/ange.201101849 · Cited by 9
SIRT2 Directs the Replication Stress Response Through CDK9 Deacetylation
Zhang, H., Park, S., Pantazides, B. G., Hardy, C. W., Seyfried, N. T., Duong, D. M., & Yu, D. S. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.07.1808 · Cited by 7
Cited by
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
The molecular hallmarks of epigenetic control
Allis, C. D., & Jenuwein, T. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.59 · Cited by 2,809
Epigenetic Determinants of Cancer
Baylin, S. B., & Jones, P. A. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019505 · Cited by 1,226
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097
“In addition to those mentioned and discussed above, histone modifications also include citrullination, ADP-ribosylation, deamination, formylation, O-GlcNAcylation, propionylation, butyrylation, crotonylation, and proline isomerization at over 60 amino acid residues.(157,158) In addition to conventional PTMs, novel PTM…”
BackgroundHeavy metals: toxicity and human health effects
Jomova, K., Alomar, S. Y., Nepovimova, E., Kuca, K., & Valko, M. (2025) · Archives of Toxicology · doi:10.1007/s00204-024-03903-2 · Cited by 983
Metadata
- Authors
- Audia, J. E., & Campbell, R. M.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-04
- Volume
- 8
- Issue
- 4
- Pages
- a019521
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2323939601
- Cited by
- 1,024
- References
- 229
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.